Trial site
Centro Hospitalar Universitario De Lisboa Norte E.P.E.
- 25running trials
- 23closed trials
The trials here
What the 48 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- High blood pressure4 trials
- Pulmonary arterial hypertension4 trials
- Epilepsy3 trials
- Head and neck cancer3 trials
- Stroke3 trials
- Asthma2 trials
- Atopic dermatitis (eczema)2 trials
- Diffuse large B-cell lymphoma2 trials
- Heart failure2 trials
- Liver and biliary tract cancer2 trials
- Lupus (SLE)2 trials
- and 18 more
- Phase
- Phase 339 trials
- Phase 26 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Completed23 trials
- Active, not recruiting14 trials
- Recruiting11 trials
- Lead sponsor
- Merck Sharp & Dohme LLC6 trials
- AbbVie4 trials
- Xenon Pharmaceuticals Inc.3 trials
- Aerovate Therapeutics Inc.2 trials
- Janssen Research & Development, LLC2 trials
- and 29 more
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Epilepsy2 recruiting
- Asthma1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lupus (SLE)1 recruiting
- Triple-negative breast cancer1 recruiting
- Wilson disease1 recruiting
Closed trials
Completed
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Active, not recruiting
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Enrolling by invitation
Completed
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Completed
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Completed
Active, not recruiting
Completed
STRIDES - A Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
Completed
Completed
A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
Completed
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026